Why not vaccinate against AI 01 May 2006
Author: Guest Bloggers
Vaccination offers a cost-effective method to suppress
clinical outbreaks and reduce the impact of highly-pathogenic avian
influenza. By Simon Shane
Vaccination offers a cost-effective method to suppress clinical outbreaks
and reduce the impact of highly-pathogenic avian influenza.
The traditional approach of detection and quarantine followed by rapid
depletion and disposal of affected flocks is appropriate in industrialized
countries with technical, logistic and economic resources to mount effective
eradication campaigns.
Attempting to eliminate avian influenza by slaughter of exposed flocks in
countries with large populations of non-commercial poultry is doomed to failure.
It is not possible to confirm infection and then slaughter and dispose of
numerous small flocks within a limited time period to achieve effective
destruction of the virus in infected and contact birds.
Traditional opposition to vaccination is based on the following
concepts:
"Vaccination obscures diagnosis since flocks have
AI antibody titers."
Avian influenza is currently diagnosed by detecting antigen using
RT-PCR and antigen capture ELISA. Demonstrating antibodies using conventional
serology is no longer an acceptable diagnostic technique.
"Vaccination leads
to persistence of virus."
In the absence of
vaccination, susceptible flocks multiply virus at such an exponential rate that
it is difficult to control. A preemptive vaccination lowers the proportion of
susceptible flocks in a region to below the outbreak threshold. It is
theoretically possible to reduce the proportion of susceptibles to below the
endemic threshold and the infection can be eradicated over time.
"Vaccination inhibits detection of infected
flocks."
Application of the DIVA principle in which a
vaccine containing homologous H antigen with a heterologous N antigen is used,
allows absolute differentiation between immunized and infected status of flocks.
As a further precaution, non-vaccinated sentinels can be placed in a flock to
indicate the presence of field virus.
"Vaccination will lead
to loss of export markets."
Most of the nations currently affected by avian
influenza are either self-sufficient or are net importers of processed poultry.
Producers and consumers in these countries have more to lose by not protecting
their flocks by using vaccine than countenancing susceptibility with the high
probability of infection and catastrophic loss.
"Vaccination will allow AI virus to persist and
result in potential mutation to a pandemic strain affecting humans."
Rapid multiplication of H5N1 virus in susceptible
poultry populations will in fact increase the probability of mutation and will
raise the level of exposure to human contacts throughout the chain of production
and consumption. Vaccination will effectively reduce the quantum of virus in
backyard and semi-commercial flocks and will limit transmission to free-living
birds which disseminate infection.
"Once vaccination is introduced, it is
necessary to continue a program forever."
Maintaining a high proportion of immune flocks
requires expenditure for both vaccine and administration. Economic models have
shown the financial benefits of a vaccination program compared to the realistic
alternative of uncontrolled spread of highly-pathogenic virus. The continuation
of poultry production in many countries in Southeast Asia and Eurasia where HPAI
has become endemic may only be possible with protection provided by vaccination,
paralleling industry practice with regard to velogenic Newcastle
disease.
"Has vaccination ever been effectively applied
to control an HPAI outbreak?"
In 1994 an outbreak of H5N2 HPAI in Mexico
extended rapidly through a number of broiler-producing states. Since a
traditional detection and slaughter program to eradicate infection was
impossible due to logistic and cost restraints, vaccination was selected as the
primary strategy for containment. Clinical cases of HPAI ceased within six
months and the virus could not be isolated from commercial and backyard flocks
after a year. Experience in the People's Republic of China has clearly
demonstrated the efficacy of diligent immunization using potent vaccines in both
commercial and subsistence flocks. Outbreaks of avian influenza during the past
two years in this country have been ascribed to deficiencies in either quality
of vaccines or their application.
"How can the
effectiveness of a vaccination program be measured?"
All vaccination programs should be subjected to a
structured surveillance program to detect the presence of virus in sentinel
birds. The immune status of flocks can be monitored using serologic techniques
including agar gel diffusion, ELISA or other procedures.
"International veterinary authorities
including the OIE disfavor the use of vaccine and promote eradication."
Regulatory authorities advocated traditional eradication programs in
response to the emerging epornitic(attacking many birds in a region at the
same time) in 2001 without
realizing the extent of infection and the lack of resources. Previous experience
gained in Western Europe and the USA was inappropriate to the situation in
Southeast Asia from 2002 onwards. Challenges included the extent of infection,
widespread distribution of flocks, live-bird marketing, deficient diagnostic
resources and the virtual absence of effective control measures in affected
countries. Resistance to change among veterinary bureaucrats, lack of
communication between the WHO and OIE, and conflicting pressures and lack of
transparency by governments, integrators and exporters in some countries
contributed to an uncoordinated and non-focused response.
With the experience gained since 2003, it is evident
that intensive vaccination is an appropriate response to control HPAI in
countries with extensive live-bird production and no export markets but only
providing that an effective AI surveillance program can be
implemented.
By: Simon Shane